Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
22 June 2022
|
|
m 00:40 | Bevacizumab (Avastin) 2 changes history -267 [Jwarner (2×)] | |||
| m |
|
00:40 (cur | prev) -263 Jwarner talk contribs →Non-small cell lung cancer, nonsquamous | |||
| m |
|
00:38 (cur | prev) -4 Jwarner talk contribs →Non-small cell lung cancer, nonsquamous | |||
21 June 2022
| m 16:52 | Pembrolizumab (Keytruda) diffhist -465 Jwarner talk contribs | ||||
|
|
m 16:29 | Bevacizumab-awwb (Mvasi) 3 changes history +274 [Jwarner (3×)] | |||
| m |
|
16:29 (cur | prev) +12 Jwarner talk contribs →History of changes in FDA indication | |||
| m |
|
16:27 (cur | prev) +21 Jwarner talk contribs →History of changes in FDA indication | |||
| m |
|
16:20 (cur | prev) +241 Jwarner talk contribs →History of changes in FDA indication | |||